Cannabis Patents For Pancreatic And Breast Cancers To Get A Review, CBIH Works On Treatment For Other Serious Conditions As rates of pancreatic and breast cancer increase among the population, ...

SAN DIEGO, March 12, 2015 /PRNewswire/ -- HUYA Bioscience International (HUYA) today announced a key addition to its Executive Team. Alain Rolland, Pharm.D., Ph.D., has been appointed as Executive ...

HOUSTON, Texas, Sept. 11, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire-- Cannabis Bioscience International Holdings (trading on the OTC Markets under the ticker symbol CBIH), a medical research company ...

Houston, Texas--(Newsfile Corp. - October 6, 2025) - Cannabis Bioscience International Holdings, Inc., (OTCID: CBIH), a publicly traded biomedical cannabis research and development company listed on ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations for ...

Niagen Bioscience, Inc. (NASDAQ: NAGE) (formerly ChromaDex Corp.), the global authority on NAD+ (nicotinamide adenine dinucleotide) with a focus on the science of healthy aging, today announced its ...

Shanghai Pharmaceutical Holding Co. Ltd. out-licensed global rights of its antitumor small-molecule chemical drug, SPH-6162, to U.S.-based Huya Bioscience International LLC in a deal worth up to ...

About Cannabis Bioscience International Holdings Inc. Cannabis Bioscience International Holdings, Inc. engages in the provision of services in therapeutic areas of clinical research. It also operates ...

LOS ANGELES--(BUSINESS WIRE)-- Niagen Bioscience, Inc. (NASDAQ: NAGE) (formerly ChromaDex Corp.), the global authority on NAD+ (nicotinamide adenine dinucleotide) with a focus on the science of ...

Entering text into the input field will update the search result below Entering text into the input field will update the search result below ...